Company Filing History:
Years Active: 2022-2025
Title: The Innovations of Stephan Ortiz
Introduction
Stephan Ortiz is a notable inventor based in Guilford, CT (US), recognized for his contributions to the field of medicine. He holds a total of 4 patents, focusing on innovative treatments for serious health conditions in pediatric patients. His work has significantly impacted the medical community, particularly in the treatment of rare diseases.
Latest Patents
Among his latest patents, Ortiz has developed methods for the dosage and administration of anti-C5 antibodies for the treatment of atypical hemolytic uremic syndrome (aHUS) in pediatric patients. This patent provides essential methods for clinical treatment using an anti-C5 antibody or an antigen-binding fragment thereof. Additionally, he has patented similar methods for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in pediatric patients, further showcasing his commitment to advancing pediatric healthcare.
Career Highlights
Stephan Ortiz is currently employed at Alexion Pharmaceuticals, Inc., where he continues to innovate and contribute to the development of life-saving treatments. His work at Alexion has positioned him as a key player in the pharmaceutical industry, particularly in the realm of rare disease therapies.
Collaborations
Throughout his career, Ortiz has collaborated with talented individuals such as Jillian Gentile and Leena Philominathan. These collaborations have fostered a creative environment that encourages the development of groundbreaking medical solutions.
Conclusion
Stephan Ortiz's contributions to medical innovation, particularly in pediatric treatments, highlight his dedication to improving patient outcomes. His patents and work at Alexion Pharmaceuticals, Inc. reflect a commitment to advancing healthcare through innovative solutions.